Agilis Biotherapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Agilis Biotherapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2017.

Profile compiled from public records. Is this your company? Request a correction or update

Agilis Biotherapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2013

SEC CIK1595971

What does Agilis Biotherapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $12.7 million sold (2017).

Frequently asked questions about Agilis Biotherapeutics

Where is Agilis Biotherapeutics headquartered?

Agilis Biotherapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Agilis Biotherapeutics do?

Agilis Biotherapeutics, Inc. is a biotechnology company.

When was Agilis Biotherapeutics founded?

The earliest incorporation on record for Agilis Biotherapeutics, Inc. is in 2013, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences